We are live on ! Find out more
TPST icon

Tempest Therapeutics
TPST

63 hedge funds and large institutions have $41.9M invested in Tempest Therapeutics in 2017 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 13 increasing their positions, 17 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,000% more call options, than puts

Call options by funds: $21K | Put options by funds: $1K

32% more capital invested

Capital invested by funds: $31.7M → $41.9M (+$10.2M)

24% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 17

25% less funds holding

Funds holding: 84 → 63 (-21)

63% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 24

Holders
63
Holders Change
-21
Holders Change %
-25%
% of All Funds
1.57%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
13
Reduced
17
Closed
24
Calls
$21K
Puts
$1K
Net Calls
+$20K
Net Calls Change
+$58K

Top Buyers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
+$5.59M
2
BlackRock
BlackRock
New York
+$2.98M
3
SM
Sabby Management
Florida
+$596K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$545K
5
GC
GMT Capital
Georgia
+$368K

Top Sellers

Rank Fund Capital Flow
1
CC
CQS Cayman
Cayman Islands
-$1.05M
2
PCM
Portolan Capital Management
Massachusetts
-$1.02M
3
AFM
Anson Funds Management
Texas
-$637K
4
Tudor Investment Corp
Tudor Investment Corp
Connecticut
-$331K
5
Northern Trust
Northern Trust
Illinois
-$289K
Name Holding Trade Value Shares
Change 		Change in
Stake
NCMW
26
Northern Capital Management (Wisconsin)
Wisconsin
$172K +$69.9K +15 +94%
Citigroup
27
Citigroup
New York
$169K -$46.6K -10 -24%
ERSOT
28
Employees Retirement System of Texas
Texas
$167K – – –
ARTA
29
A.R.T. Advisors
New York
$161K +$140K +30 New
TA
30
Teachers Advisors
New York
$127K – – –
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$121K – – –
Susquehanna International Group
32
Susquehanna International Group
Pennsylvania
$113K -$46.6K -10 -32%
Charles Schwab
33
Charles Schwab
California
$107K – – –
UBS AM
34
UBS AM
Illinois
$107K +$88.5K +19 New
AllianceBernstein
35
AllianceBernstein
Tennessee
$90K -$4.66K -1 -6%
New York State Common Retirement Fund
36
New York State Common Retirement Fund
New York
$90K – – –
Swiss National Bank
37
Swiss National Bank
Switzerland
$83K – – –
IG
38
ING Group
Netherlands
$75K +$65.2K +14 New
SIP
39
Stoneridge Investment Partners
Pennsylvania
$67K -$23.3K -5 -29%
OC
40
Oppenheimer & Co
New York
$66K -$14K -3 -20%
SKK
41
Shepherd Kaplan Krochuk
Massachusetts
$65K +$55.9K +12 New
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$56K -$9.31K -2 -17%
SG Americas Securities
43
SG Americas Securities
New York
$55K +$46.6K +10 New
California Public Employees Retirement System
44
California Public Employees Retirement System
California
$50K -$4.66K -1 -10%
NFA
45
Nationwide Fund Advisors
Ohio
$38K – – –
AIG
46
American International Group
New York
$36K +$4.66K +1 +17%
Dimensional Fund Advisors
47
Dimensional Fund Advisors
Texas
$33K -$4.66K -1 -14%
UBS Group
48
UBS Group
Switzerland
$32K +$14K +3 +100%
VOYA Investment Management
49
VOYA Investment Management
Georgia
$29K – – –
Deutsche Bank
50
Deutsche Bank
Germany
$23K -$130K -28 -88%
1
2
3 4

TPST Hedge Fund Activity: Q1 2017 in Review

63 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Tempest Therapeutics (TPST) for Q1 2017, worth a combined $41.9M — up 32% from $31.7M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of TPST and 9 opened new positions — a net loss of 15 holders — while 17 trimmed existing stakes and 13 added.

The largest buyer was EcoR1 Capital, opening a new position worth an estimated $5.59M. The largest seller was CQS Cayman, exiting entirely with an estimated $1.05M sold.

  • 63 institutional investors held Tempest Therapeutics (TPST) as of Q1 2017, down from 84 in Q4 2016.
  • Funds reported $41.9M of Tempest Therapeutics stock for Q1 2017, up 32% quarter-over-quarter.
  • 9 funds opened new Tempest Therapeutics positions in Q1 2017 and 24 closed out, a net change of -15 holders.
  • The largest Tempest Therapeutics buyer in Q1 2017 was EcoR1 Capital, an estimated $5.59M added.
  • The largest Tempest Therapeutics seller in Q1 2017 was CQS Cayman, an estimated $1.05M sold.

Based on aggregated 13F filings for Q1 2017.